The weekly litigation news digest is live. Subscribe now

Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc - 2:24-cv-09135

Boehringer Ingelheim Pharmaceuticals, Inc. V. Anobri Pharmaceuticals Us, Llc (Case No. 2:24-cv-09135), filed on Sep 12, 2024 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
2:24-cv-09135
Filing Date
Sep 12, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
BOEHRINGER INGELHEIM INTERNATIONAL GMBH -
NANCHANG ANOVENT PHARMACEUTICAL CO., LTD. -
SHANGHAI ANOVENT PHARMACEUTICAL CO., LTD. -
ANOBRI PHARMACEUTICALS US, LLC -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

Docket entries not found - set an alert to get notified when docket entries are added.